光疗、阿达木单抗和倍他米松-卡泊三醇对银屑病效应T细胞与调节性T细胞的差异作用
研究采用流式细胞术检测银屑病患者接受窄谱中波紫外线、阿达木单抗或局部倍他米松-卡泊三醇治疗前后血液和皮肤中Th1、Th2、Th17及调节性T细胞数量,发现三种疗法对Th17与调节性T细胞的作用不同,且所有患者临床均有应答。
要点
- 窄谱中波紫外线显著增加循环和皮肤中的调节性T细胞数量。
- 阿达木单抗减少循环和皮肤中的Th17细胞。
- 倍他米松-卡泊三醇兼具增加调节性T细胞和减少Th17细胞的双重作用。
核心结论
- 所报告的上述治疗方式的差异作用可用于优化或设计治疗策略,以更有效克服炎症驱动因素并恢复银屑病中的Th17-Treg平衡。
研究设计与样本
- 研究采用流式细胞术,在银屑病患者接受窄谱中波紫外线、阿达木单抗或局部倍他米松-卡泊三醇复方制剂治疗前后,计数血液和皮肤中的Th1、Th2、Th17及调节性T细胞亚群。
主要发现
- 所有患者对治疗均有临床应答。
- 窄谱中波紫外线显著增加循环和皮肤中的调节性T细胞数量。
- 阿达木单抗减少循环和皮肤中的Th17细胞。
- 倍他米松-卡泊三醇具有双重作用,既增加调节性T细胞又减少Th17细胞。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psoriasis is a chronic T-cell-mediated skin disease with marked social and economic burdens. Current treatments are unsatisfactory, with unpredictable remission times and incompletely understood modes of action. Recent advances in our understanding of the pathogenesis of psoriasis have identified the imbalance between CD4+ T effector cells, particularly the T helper (Th)17 subset, and regulatory T cells (Tregs) as key to the development of psoriatic lesions, and therefore a novel therapeutic target. OBJECTIVES: To quantify in patients the effects of three commonly used psoriasis treatment modalities on the Th1, Th2, Th17 and Treg subsets, and to test whether any change correlates with clinical response. METHODS: Flow cytometry was used to enumerate Th1, Th2, Th17 and Treg subsets in blood and skin of patients with psoriasis before and after receiving any of the following treatments: narrowband ultraviolet B (NB-UVB), adalimumab and topical betamethasone-calcipotriol combination (Dovobet® ) RESULTS: All patients responded clinically to the treatments. NB-UVB significantly increased the numbers of circulating and skin Tregs, while, by contrast, adalimumab reduced Th17 cells in these compartments, and Dovobet had dual effects by both increasing Tregs and reducing Th17 cells. CONCLUSIONS: The differential effects reported here for the above-mentioned treatment modalities could be exploited to optimize or design therapeutic strategies to overcome the inflammatory drivers more effectively and restore the Th17-Treg balance in psoriasis.
引用
- Kotb IS, Lewis BJ, Barker RN, et al. Differential effects of phototherapy, adalimumab and betamethasone-calcipotriol on effector and regulatory T cells in psoriasis. Br J Dermatol. 2018. PMID: 29330859. doi:10.1111/bjd.16336
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。